Masked Hypertension
10
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
50%
5 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (10)
MASked-unconTrolled hypERtension Management Based on Office BP or on Out-of-office (Ambulatory) BP Measurement
Antihypertensive Treatment in Masked Hypertension
Masked Hypertensive Patients With Obstructive Sleep Apnea
Arterial Function After Two Different Physical Exercise Intensities in Prehypertension
Screening for Masked Hypertension With Smart Wearable Devices (SMART)
Mechanism of Masked Hypertension - Intervention
Prevalence of Masked Hypertension in Nephrological Patients
Treatment of Masked Hypertension
Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes
The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension